FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124879501> ?p ?o ?g. }

• W2124879501 endingPage "458" @default.
• W2124879501 startingPage "446" @default.
• W2124879501 abstract "Background and Purpose Here, we have characterized 3‐cyclopropyl‐1‐(4‐(6‐((1,1‐dioxidothiomorpholino)methyl)‐5‐fluoropyridin‐2‐yl)benzyl)imidazolidine‐2,4‐dione hydrochloride (LEI‐101) as a novel, peripherally restricted cannabinoid CB 2 receptor agonist, using both in vitro and in vivo models. Experimental Approach We investigated the effects of LEI‐101 on binding and functional activity. We assessed its in vitro and in vivo selectivity. Efficacy of LEI‐101 was determined in a mouse model of cisplatin‐induced nephrotoxicity. Key Results LEI‐101 behaved as a partial agonist at CB 2 receptors using β ‐arrestin and GTP γ S assays and was ~100‐fold selective in CB 2 /CB 1 receptor‐binding assays. It did not display any activity on endocannabinoid hydrolases and nor did it react with serine hydrolases in an activity‐based protein profiling assay. In mice, LEI‐101 had excellent oral bioavailability reaching high concentrations in the kidney and liver with minimal penetration into the brain. LEI‐101 up to a dose of 60 mg·kg −1 (p.o.) did not exert any CNS‐mediated effects in the tetrad assay, in mice. LEI‐101 (p.o. or i.p.) at 3 or 10 mg·kg −1 dose‐dependently prevented kidney dysfunction and/or morphological damage induced by cisplatin in mice. These protective effects were associated with improved renal histopathology, attenuated oxidative stress and inflammation in the kidney. These effects were absent in CB 2 receptor knockout mice. Conclusion and Implications These results indicate that LEI‐101 is a selective, largely peripherally restricted, orally available CB 2 receptor agonist with therapeutic potential in diseases that are associated with inflammation and/or oxidative stress, including kidney disease." @default.
• W2124879501 created "2016-06-24" @default.
• W2124879501 creator A5001540053 @default.
• W2124879501 creator A5016103616 @default.
• W2124879501 creator A5017608631 @default.
• W2124879501 creator A5019665145 @default.
• W2124879501 creator A5022995099 @default.
• W2124879501 creator A5026132845 @default.
• W2124879501 creator A5047428609 @default.
• W2124879501 creator A5066586472 @default.
• W2124879501 creator A5067630914 @default.
• W2124879501 creator A5072458208 @default.
• W2124879501 creator A5073541643 @default.
• W2124879501 creator A5074185770 @default.
• W2124879501 creator A5078181630 @default.
• W2124879501 creator A5084119264 @default.
• W2124879501 creator A5084426055 @default.
• W2124879501 creator A5084489352 @default.
• W2124879501 creator A5086682653 @default.
• W2124879501 creator A5090161229 @default.
• W2124879501 date "2016-01-15" @default.
• W2124879501 modified "2023-10-16" @default.
• W2124879501 title "The novel, orally available and peripherally restricted selective cannabinoid CB₂ receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity" @default.
• W2124879501 cites W1529023379 @default.
• W2124879501 cites W1644289333 @default.
• W2124879501 cites W1701529362 @default.
• W2124879501 cites W1943422062 @default.
• W2124879501 cites W1964395752 @default.
• W2124879501 cites W1971721792 @default.
• W2124879501 cites W1971825415 @default.
• W2124879501 cites W1971955583 @default.
• W2124879501 cites W1983965827 @default.
• W2124879501 cites W1993407667 @default.
• W2124879501 cites W1997487942 @default.
• W2124879501 cites W1998464082 @default.
• W2124879501 cites W2002201401 @default.
• W2124879501 cites W2006605504 @default.
• W2124879501 cites W2011098728 @default.
• W2124879501 cites W2021681296 @default.
• W2124879501 cites W2028879462 @default.
• W2124879501 cites W2036073332 @default.
• W2124879501 cites W2052025850 @default.
• W2124879501 cites W2070535004 @default.
• W2124879501 cites W2074561249 @default.
• W2124879501 cites W2081804788 @default.
• W2124879501 cites W2082237701 @default.
• W2124879501 cites W2096703732 @default.
• W2124879501 cites W2096748864 @default.
• W2124879501 cites W2108416430 @default.
• W2124879501 cites W2122386753 @default.
• W2124879501 cites W2135530906 @default.
• W2124879501 cites W2141551684 @default.
• W2124879501 cites W2143425403 @default.
• W2124879501 cites W2143544679 @default.
• W2124879501 cites W2144797452 @default.
• W2124879501 cites W2150873636 @default.
• W2124879501 cites W2155801131 @default.
• W2124879501 cites W2163953252 @default.
• W2124879501 cites W2166806732 @default.
• W2124879501 cites W2171530795 @default.
• W2124879501 cites W2331902399 @default.
• W2124879501 cites W2404147365 @default.
• W2124879501 doi "https://doi.org/10.1111/bph.13338" @default.
• W2124879501 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4728411" @default.
• W2124879501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26398481" @default.
• W2124879501 hasPublicationYear "2016" @default.
• W2124879501 type Work @default.
• W2124879501 sameAs 2124879501 @default.
• W2124879501 citedByCount "54" @default.
• W2124879501 countsByYear W21248795012016 @default.
• W2124879501 countsByYear W21248795012017 @default.
• W2124879501 countsByYear W21248795012018 @default.
• W2124879501 countsByYear W21248795012019 @default.
• W2124879501 countsByYear W21248795012020 @default.
• W2124879501 countsByYear W21248795012021 @default.
• W2124879501 countsByYear W21248795012022 @default.
• W2124879501 countsByYear W21248795012023 @default.
• W2124879501 crossrefType "journal-article" @default.
• W2124879501 hasAuthorship W2124879501A5001540053 @default.
• W2124879501 hasAuthorship W2124879501A5016103616 @default.
• W2124879501 hasAuthorship W2124879501A5017608631 @default.
• W2124879501 hasAuthorship W2124879501A5019665145 @default.
• W2124879501 hasAuthorship W2124879501A5022995099 @default.
• W2124879501 hasAuthorship W2124879501A5026132845 @default.
• W2124879501 hasAuthorship W2124879501A5047428609 @default.
• W2124879501 hasAuthorship W2124879501A5066586472 @default.
• W2124879501 hasAuthorship W2124879501A5067630914 @default.
• W2124879501 hasAuthorship W2124879501A5072458208 @default.
• W2124879501 hasAuthorship W2124879501A5073541643 @default.
• W2124879501 hasAuthorship W2124879501A5074185770 @default.
• W2124879501 hasAuthorship W2124879501A5078181630 @default.
• W2124879501 hasAuthorship W2124879501A5084119264 @default.
• W2124879501 hasAuthorship W2124879501A5084426055 @default.
• W2124879501 hasAuthorship W2124879501A5084489352 @default.
• W2124879501 hasAuthorship W2124879501A5086682653 @default.
• W2124879501 hasAuthorship W2124879501A5090161229 @default.
• W2124879501 hasBestOaLocation W21248795011 @default.
• W2124879501 hasConcept C103133801 @default.

• next